These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23318177)

  • 21. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
    Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
    Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piperlongumine selectively kills cancer cells and increases cisplatin antitumor activity in head and neck cancer.
    Roh JL; Kim EH; Park JY; Kim JW; Kwon M; Lee BH
    Oncotarget; 2014 Oct; 5(19):9227-38. PubMed ID: 25193861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An historic perspective of proteasome inhibition.
    Esseltine DL; Mulligan G
    Semin Hematol; 2012 Jul; 49(3):196-206. PubMed ID: 22726542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome-associated deubiquitinases and cancer.
    Mofers A; Pellegrini P; Linder S; D'Arcy P
    Cancer Metastasis Rev; 2017 Dec; 36(4):635-653. PubMed ID: 29134486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound.
    Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson AL; Johnsen JI; Dantuma NP
    Cell Death Dis; 2021 Oct; 12(10):914. PubMed ID: 34615851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovering proteasomal deubiquitinating enzyme inhibitors for cancer therapy: lessons from rational design, nature and old drug reposition.
    Patel K; Ahmed ZS; Huang X; Yang Q; Ekinci E; Neslund-Dudas CM; Mitra B; Elnady FA; Ahn YH; Yang H; Liu J; Dou QP
    Future Med Chem; 2018 Sep; 10(17):2087-2108. PubMed ID: 30066579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction.
    Bonfili L; Cuccioloni M; Cecarini V; Mozzicafreddo M; Palermo FA; Cocci P; Angeletti M; Eleuteri AM
    Apoptosis; 2013 Oct; 18(10):1188-200. PubMed ID: 23632965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.
    Lee YJ; Seol JW; Jeong JK; Moon MH; Park SY
    Mol Med Rep; 2011; 4(6):1255-9. PubMed ID: 21850375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCF11/Nrf1-Mediated Induction of Proteasome Expression Prevents Cytotoxicity by Rotenone.
    Sotzny F; Schormann E; Kühlewindt I; Koch A; Brehm A; Goldbach-Mansky R; Gilling KE; Krüger E
    Antioxid Redox Signal; 2016 Dec; 25(16):870-885. PubMed ID: 27345029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of 4-arylidene curcumin analogues as novel proteasome inhibitors for potential anticancer agents targeting 19S regulatory particle associated deubiquitinase.
    Yue X; Zuo Y; Ke H; Luo J; Lou L; Qin W; Wang Y; Liu Z; Chen D; Sun H; Zheng W; Zhu C; Wang R; Wen G; Du J; Zhou B; Bu X
    Biochem Pharmacol; 2017 Aug; 137():29-50. PubMed ID: 28476333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells.
    Nehybová T; Šmarda J; Daniel L; Stiborek M; Kanický V; Spasojevič I; Preisler J; Damborský J; Beneš P
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitin is degraded by the ubiquitin system as a monomer and as part of its conjugated target.
    Shabek N; Iwai K; Ciechanover A
    Biochem Biophys Res Commun; 2007 Nov; 363(2):425-31. PubMed ID: 17870054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
    Wyke SM; Tisdale MJ
    Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of proteasome inhibitors using analysis of gene expression profiles.
    Mofers A; Selvaraju K; Gubat J; D'Arcy P; Linder S
    Eur J Pharmacol; 2020 Dec; 889():173709. PubMed ID: 33166494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent Patents on Proteasome Inhibitors of Natural Origin.
    da Silva DC; Andrade PB; Ribeiro V; Valentao P; Pereira DM
    Recent Pat Anticancer Drug Discov; 2017; 12(1):4-15. PubMed ID: 27881056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
    Menéndez-Benito V; Verhoef LG; Masucci MG; Dantuma NP
    Hum Mol Genet; 2005 Oct; 14(19):2787-99. PubMed ID: 16103128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
    Kessova IG; Cederbaum AI
    J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
    Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
    J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome.
    Bosc E; Nastri J; Lefort V; Valli M; Contiguiba F; Pioli R; Furlan M; Bolzani VDS; El Amri C; Reboud-Ravaux M
    Biochem Biophys Res Commun; 2018 Feb; 496(3):961-966. PubMed ID: 29355526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.